Clinicopathological features and prognosis of gastric adenocarcinoma with enteroblastic differentiation

doi:10.4251/wjgo.121562

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 9

This Article

(18)

(11)

(0)

(8)

(135)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Sep 15, 2026; 18(9): 121562
Published online Sep 15, 2026. doi: 10.4251/wjgo.121562

Table 4 Univariate and multivariate survival analysis between gastric adenocarcinoma with enteroblastic differentiation group and gastric cancer group in pTNM I-III patients

Prognostic factors	Univariate analysis¹			Multivariate analysis¹			Univariate analysis²			Multivariate analysis²
Prognostic factors	HR	95%CI	P value	HR	95%CI	P value	HR	95%CI	P value	HR	95%CI	P value
pTNM I
GC group	1.000			1.000			1.000			1.000
GAED group	1.091	0.364-3.267	0.896	-	-	-	1.102	0.368-3.300	0.884	-	-	-
pTNM II
GC group	1.000			1.000			1.000			1.000
GAED group	0.586	0.232-1.485	0.345	-	-	-	0.593	0.234-1.498	0.354	-	-	-
pTNM III
GC group	1.000			1.000			1.000			1.000
GAED group	2.402	1.639-3.519	< 0.01	1.545	0.919-2.597	0.168	2.493	1.706-3.644	< 0.01	1.640	1.034-2.879	0.048

¹Overall survival.

²Progression free survival.

Variables with a P value < 0.05 in univariate analysis were ultimately included in the multivariate analysis. HR: Hazard ratio; CI: Confidence interval; GC: Gastric cancer; GAED: Gastric adenocarcinoma with enteroblastic differentiation; TNM: Tumor-node-metastasis.

Full Size Table

Citation: Wen ZL, Ren H, Niu PH, Fei H, Li ZF, Zhao DB. Clinicopathological features and prognosis of gastric adenocarcinoma with enteroblastic differentiation. World J Gastrointest Oncol 2026; 18(9): 121562
URL: https://www.wjgnet.com/1948-5204/full/v18/i9/121562.htm
DOI: https://dx.doi.org/10.4251/wjgo.121562

Wen ZL, Ren H, Niu PH, Fei H, Li ZF, Zhao DB. Clinicopathological features and prognosis of gastric adenocarcinoma with enteroblastic differentiation. World J Gastrointest Oncol 2026; 18(9): 121562 [DOI: 10.4251/wjgo.121562]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.